Dr. Martens Dividends and Buybacks
Dividend criteria checks 3/6
Dr. Martens is a dividend paying company with a current yield of 5% that is well covered by earnings.
Key information
5.0%
Dividend yield
6.1%
Buyback Yield
| Total Shareholder Yield | 11.1% |
| Future Dividend Yield | 5.3% |
| Dividend Growth | 2.4% |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | UK£0.0255 |
| Payout ratio | 60% |
Recent dividend and buyback updates
Dr. Martens' (LON:DOCS) Dividend Will Be £0.0156
Jan 03
Dr. Martens (LON:DOCS) Will Pay A Dividend Of £0.0156
Dec 13Recent updates
Dr. Martens (LON:DOCS) May Have Issues Allocating Its Capital
Apr 15
Cost Savings Ahead Of Schedule Will Improve Profitability By FY '26
Mar 14 Strategic focus on premium positioning, demand planning, and cost reductions aims to enhance revenue, margins, and profitability.Earnings Tell The Story For Dr. Martens plc (LON:DOCS) As Its Stock Soars 27%
Dec 06Dr. Martens plc (LON:DOCS) Half-Yearly Results: Here's What Analysts Are Forecasting For This Year
Dec 01Benign Growth For Dr. Martens plc (LON:DOCS) Underpins Stock's 30% Plummet
Sep 21Is There An Opportunity With Dr. Martens plc's (LON:DOCS) 45% Undervaluation?
Aug 20Dr. Martens (LON:DOCS) Has Some Way To Go To Become A Multi-Bagger
Jul 20There May Be Some Bright Spots In Dr. Martens' (LON:DOCS) Earnings
Jun 19Dr. Martens plc's (LON:DOCS) Price Is Right But Growth Is Lacking After Shares Rocket 27%
May 21The Trend Of High Returns At Dr. Martens (LON:DOCS) Has Us Very Interested
Mar 27Dr. Martens (LON:DOCS) Has A Somewhat Strained Balance Sheet
Mar 06Dr. Martens plc's (LON:DOCS) Intrinsic Value Is Potentially 57% Above Its Share Price
Feb 08Dr. Martens plc's (LON:DOCS) Business And Shares Still Trailing The Market
Jan 21Dr. Martens' (LON:DOCS) Dividend Will Be £0.0156
Jan 03Dr. Martens (LON:DOCS) Will Pay A Dividend Of £0.0156
Dec 13Dr. Martens (LON:DOCS) Is Very Good At Capital Allocation
Oct 12Calculating The Intrinsic Value Of Dr. Martens plc (LON:DOCS)
Sep 13Returns on Capital Paint A Bright Future For Dr. Martens (LON:DOCS)
Jul 12A Look At The Intrinsic Value Of Dr. Martens plc (LON:DOCS)
Jun 02Dr. Martens (LON:DOCS) Is Investing Its Capital With Increasing Efficiency
Feb 25Is There An Opportunity With Dr. Martens plc's (LON:DOCS) 34% Undervaluation?
Dec 17The Trend Of High Returns At Dr. Martens (LON:DOCS) Has Us Very Interested
Oct 02Dr. Martens (LON:DOCS) Knows How To Allocate Capital Effectively
Jul 04Why Investors Shouldn't Be Surprised By Dr. Martens plc's (LON:DOCS) 26% Share Price Surge
Jun 16Stability and Growth of Payments
Fetching dividends data
Stable Dividend: DOCS has been paying a dividend for less than 10 years and during this time payments have been volatile.
Growing Dividend: DOCS's dividend payments have increased, but the company has only paid a dividend for 3 years.
Dividend Yield vs Market
| Dr. Martens Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (DOCS) | 5.0% |
| Market Bottom 25% (GB) | 2.4% |
| Market Top 25% (GB) | 6.2% |
| Industry Average (Luxury) | 2.1% |
| Analyst forecast (DOCS) (up to 3 years) | 5.3% |
Notable Dividend: DOCS's dividend (5%) is higher than the bottom 25% of dividend payers in the UK market (2.4%).
High Dividend: DOCS's dividend (5%) is low compared to the top 25% of dividend payers in the UK market (6.18%).
Earnings Payout to Shareholders
Earnings Coverage: With its reasonable payout ratio (59.8%), DOCS's dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its low cash payout ratio (12.1%), DOCS's dividend payments are thoroughly covered by cash flows.
Discover strong dividend paying companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/04/16 18:26 |
| End of Day Share Price | 2025/04/16 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Dr. Martens plc is covered by 13 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Richard Taylor | Barclays |
| Anne Critchlow | Berenberg |
| David Roux | BofA Global Research |